Merck & Co. Inc (NYSE: MRK) To Move Forward with Plans To Purchase Seagen Inc

According to sources familiar with the matter, Merck & Co. Inc (NYSE: MRK) is moving forward with a possible acquisition of Seagen Inc.. This would be one of the biggest acquisitions of the year. Merck is in discussions to acquire Seagen to expand the cancer medication lineup Last week, The Wall Street Journal reported that […]

Merck & Co., Inc (NYSE: MRK) Gains A Upper Hand Against Pfizer Inc (NYSE: PFE) In Timing Of next-gen Pneumococcal Vaccines For Kids

Pfizer Inc (NYSE: PFE) and Merck & Co., Inc (NYSE: MRK) are in race to expedite the launch of next-gen pneumococcal vaccines by the end of this year. However, Merck gains an upper hand for kids’ vaccines. Timing advantage In a communiqué, Merck said its V114 completed the efficacy and safety thresholds in two phase 3 […]

NuvaRing, Zilmax Add Further Trouble To Merck & Co., Inc. (NYSE:MRK)’s Financial Slide

Boston, MA 03/18/2014 (wallstreetpr) – Even as several new pharmacy companies are reporting new inventions that may boost their image as well as revenue biggies like Merck & Co., Inc. (NYSE:MRK) are clearly struggling to retain their hold. As per the Q4 results of FY 13, MRK’s revenue slid to $11.30 billion for the quarter which […]

$688 Million “ENHANCE” Settlement Could Pull Merck’s Q4, 2012 EPS By 16 Cents

Boston, MA 02/14/2013 (wallstreetpr) – The renowned healthcare solution provider, Merck & Co Inc., (NYSE: MRK) have settled two US investor-lawsuits for $688 million, it declared yesterday. The company was sued by several of its institutional investors (pension funds) in a class action lawsuit over knowingly withholding information about the potential of failure in another […]